
Applied Biosystems is owned by Thermo Fisher Scientific Inc. (NYSE: TMO), the publicly traded life sciences company headquartered in Waltham, Massachusetts. The brand, founded in 1981 in Foster City, California, makes genetic analysis instruments including PCR systems and DNA sequencers. It entered Thermo Fisher's portfolio through the 2014 acquisition of Life Technologies.
Parent Company
Acquired
2014
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Applied Biosystems | Thermo Fisher Scientific Inc. | Brand division |
Sam Eletr and Andre Marion, scientists at Hewlett-Packard, founded Applied Biosystems in 1981 in Foster City, California. The company commercialized automated instruments for protein sequencing and DNA synthesis, then moved decisively into DNA sequencing.
Its 1987 launch of the ABI 370A automated DNA sequencer changed genomics. Applied Biosystems sequencers became the standard instruments of the Human Genome Project, and the ABI PRISM line dominated capillary electrophoresis sequencing through the 1990s. The company also built a leading position in real-time PCR with its thermal cycler and detection systems.
Corporate structure shifted repeatedly. Perkin-Elmer built a stake in the company in the early 1990s, formed the PE Biosystems division, and in 2000 the life sciences business took the Applied Biosystems name under a new holding company called Applera. In 2008, Applied Biosystems merged with Invitrogen to create Life Technologies, headquartered in Carlsbad, California.
Thermo Fisher announced the $13.6 billion Life Technologies acquisition in 2013 and completed it in February 2014, at the time its largest deal ever. Applied Biosystems was folded into the Genetic Sciences and Life Sciences businesses, and the brand continued on PCR instruments, genetic analyzers, and forensic kits.
Under Thermo Fisher, Applied Biosystems platforms remained standard in clinical laboratories and forensic DNA testing. QuantStudio real-time PCR systems and SeqStudio and 3500 series genetic analyzers anchor the current lineup. The brand's instruments were heavily used in PCR testing infrastructure during the COVID-19 pandemic.
Who owns Thermo Fisher Scientific?
Thermo Fisher Scientific is an independent publicly traded company listed on the NYSE under TMO. No single shareholder controls it; ownership is spread across institutional investors and the public.
When was Thermo Fisher formed?
Thermo Fisher Scientific was created in 2006 by the merger of Thermo Electron, founded in 1956, and Fisher Scientific, founded in 1902.
What brands does Thermo Fisher own?
Its major brands are Thermo Scientific, Fisher Scientific, Applied Biosystems, Invitrogen, Unity Lab Services, Patheon, and PPD.
Who is the CEO of Thermo Fisher?
Marc Casper has been chairman, president, and CEO since 2009. He joined Thermo Electron in 2001 and led the company through the 2006 merger.
What was Thermo Fisher's revenue in 2025?
Revenue was $44.56 billion in fiscal 2025, up 4% from $42.88 billion in 2024. GAAP diluted EPS was $17.74.
What does PPD do?
PPD is Thermo Fisher's contract research organization, acquired in 2021 for $17.4 billion. It manages clinical trials and development programs for pharmaceutical and biotech clients.
Applied Biosystems products operate within FDA and international diagnostic regulation and have been subject to periodic field corrections and recalls typical for instrument makers, including software and performance issues on specific genetic analyzer models. The parent company faced criticism for sales of DNA analysis equipment in Xinjiang, China; Thermo Fisher said in 2021 it would stop such sales in the region, a matter that involved Applied Biosystems-branded human identification products.
No direct competitors found in the same category. This could be because Applied Biosystemsoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by Thermo Fisher Scientific Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
Availity is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
Benadryl is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
MD Clarity is privately owned, unlike Applied Biosystems which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.